What is INNV's health score?

InnovAge Holding Corp. (INNV) has a TradeApes health score of 61 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is INNV's estimated fair value?

Based on our 5-year discounted cash flow model, InnovAge Holding Corp.'s estimated fair value is $7.5 per share, representing a 5.9% upside from the current price. This is a model estimate, not a price target or investment recommendation.

Is INNV undervalued or overvalued?

Our model currently rates INNV as Fair Value. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for INNV... Refresh in a moment for the full analysis.

InnovAge Holding Corp. (INNV)

Healthcare Fair Value low healthy

$7.08

Updated: 2026-06-04

TradeApes Score

Financial Strength

60 Healthy

Operating Trend

58 Mixed

Relative Value

63 Healthy

Capital Allocation

55 Mixed

Risk

70 Healthy

Est. Fair Value $7.5

DCF Upside +5.9%

Sector Rank #3581 of 6795

Key Findings

+ Net cash position — more cash on hand than total debt

Unlock Full Report →

− Weak interest coverage — earnings barely cover debt service

Unlock Full Report →

4 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.